Your browser doesn't support javascript.
loading
Sustained responses after anti-CD38 treatment with daratumumab in two patients with refractory systemic lupus erythematosus.
Alexander, Tobias; Ostendorf, Lennard; Biesen, Robert; Schneider, Udo; Burmester, Gerd R; Hiepe, Falk.
Afiliación
  • Alexander T; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany tobias.alexander@charite.de.
  • Ostendorf L; Deutsches Rheuma-Forschungszentrum (DRFZ), Berlin, an Institute of the Leibniz Association, Autoimmunology Group, Berlin, Germany.
  • Biesen R; Deutsches Rheuma-Forschungszentrum (DRFZ), Berlin, an Institute of the Leibniz Association, Autoimmunology Group, Berlin, Germany.
  • Schneider U; Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.
  • Burmester GR; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.
  • Hiepe F; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.
Ann Rheum Dis ; 82(11): 1497-1499, 2023 Nov.
Article en En | MEDLINE | ID: mdl-37402488

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Ann Rheum Dis Año: 2023 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Ann Rheum Dis Año: 2023 Tipo del documento: Article País de afiliación: Alemania